ENKAM Pharmaceuticals A/S

_____________________________________ 

ENKAM Pharmaceuticals A/S is a Copenhagen-based biotechnology company focused on the discovery and development of peptides for the treatment of CNS disorders and cancer and for stem cell applications. ENKAM has used structural proteomics tools and bio-informatics on protein-protein interactions to discover bioactive peptides. Over 50 peptide families have been identified and patents covering them have been filed. The latest in a series of grants from the EU was announced in Q4 2011 after extensive peer review. The EU awarded a €6 million grant to an Enkam-led consortium in Q4 2011 to fund a clinical study in Alzheimer's disease of Enkam's novel lead development candidate, FGLs, which has demonstrated positive effects in neurodegeneration in Alzheimer's disease.

Download company fact sheet: FactSheet

 

 

  • ENKAM Pharmaceuticals A/S
  • Fruebjergvej 3, Box 58
  • 2100 Copenhagen Ø
  • Denmark
  • Phone: +4539179715
  • Fax: +4539179714